Patients with inflammatory bowel disease (IBD) are at a significantly increased risk of colitis-associated colorectal cancer (CAC). The relationship between intestinal flora metabolites and CAC has attracted much attention. Regulating intestinal flora metabolism or increasing beneficial metabolites may play an important role in preventing CAC. This article reviewed the role of intestinal flora metabolites in CAC.